EASL Video Podcasts

In this EASL DeepDive held on 06 November 2024, Alice Turner, Pavel Strnad, and Nicola Brunetti discuss and explore the changing insights in the management of Alpha-1 Antitrypsin Deficiency.
Learning objectives:
Learn more about the role of heterozygosity of alpha-1 as a risk factor for chronic liver disease, especially in the context of other causes such as MASLD or alcohol
Get a better understanding of the extrahepatic manifestations and the need for a multi-disciplinary approach
Learn more about screening: who to screen and how
Discover the general unmet needs related to AAT, with an emphasis on awareness and timely diagnosis
This EASL DeepDive webinar is supported by Takeda Pharmaceuticals. Takeda Pharmaceuticals has had no input into the content of this EASL DeepDive.

In this EASL DeepDive held on 25 February 2025,  Ana Lleo, Adriaan van der Meer, Gideon Hirschfield, and Bettina Hansen explore the future of primary biliary cholangitis (PBC) treatment. Discover the emerging therapies, current challenges and personalised approaches that are shaping the management of PBC.
Learning objectives
Learn more about the molecular mechanisms underlying the disease and the potential targets for drug therapy
Get a good understanding of the efficacy of the current drugs and the potential added value of the upcoming second line treatments for PBC and where to position these new treatments in the treatment landscape
Learn more about the evolving concepts regarding the endpoints in clinical trials for PBC
Get insights in the risk assessment of people living with PBC and criteria for second line therapy 
This EASL DeepDive webinar is supported by Gilead. Gilead has had no input into the content of this EASL DeepDive.